Merit Medical Systems (NASDAQ:MMSI) Updates FY 2025 Earnings Guidance

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) updated its FY 2025 earnings guidance on Friday. The company provided earnings per share guidance of 3.280-3.410 for the period, compared to the consensus earnings per share estimate of 3.350. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on MMSI. Needham & Company LLC lifted their price objective on Merit Medical Systems from $100.00 to $108.00 and gave the company a "buy" rating in a research report on Thursday, May 15th. Piper Sandler reiterated an "overweight" rating and issued a $110.00 price objective (up previously from $106.00) on shares of Merit Medical Systems in a research report on Friday, May 23rd. Robert W. Baird dropped their target price on Merit Medical Systems from $111.00 to $110.00 and set an "outperform" rating for the company in a research report on Friday, April 25th. Canaccord Genuity Group set a $112.00 price target on Merit Medical Systems and gave the company a "buy" rating in a research note on Wednesday, May 21st. Finally, JPMorgan Chase & Co. initiated coverage on Merit Medical Systems in a research note on Friday, March 28th. They set an "overweight" rating and a $120.00 price target on the stock. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $109.11.

Merit Medical Systems Trading Down 0.6%

NASDAQ MMSI traded down $0.60 on Friday, reaching $92.97. The company had a trading volume of 619,354 shares, compared to its average volume of 531,309. The stock's 50 day moving average is $94.42 and its 200-day moving average is $99.67. The stock has a market cap of $5.49 billion, a price-to-earnings ratio of 45.57, a PEG ratio of 2.34 and a beta of 0.66. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57. Merit Medical Systems has a 52 week low of $80.02 and a 52 week high of $111.45.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The medical instruments supplier reported $0.86 EPS for the quarter, beating analysts' consensus estimates of $0.75 by $0.11. The business had revenue of $355.35 million during the quarter, compared to the consensus estimate of $352.57 million. Merit Medical Systems had a return on equity of 15.61% and a net margin of 9.05%. The firm's revenue was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.77 earnings per share. Equities analysts predict that Merit Medical Systems will post 3.37 earnings per share for the current year.

Insider Activity at Merit Medical Systems

In related news, Director F. Ann Millner sold 21,250 shares of the company's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $96.47, for a total value of $2,049,987.50. Following the completion of the sale, the director now owns 34,543 shares in the company, valued at approximately $3,332,363.21. This represents a 38.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Fred P. Lampropoulos sold 20,000 shares of the company's stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $96.54, for a total value of $1,930,800.00. Following the completion of the sale, the chief executive officer now owns 1,066,028 shares of the company's stock, valued at $102,914,343.12. This represents a 1.84% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 70,415 shares of company stock worth $6,748,214. 3.20% of the stock is owned by insiders.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Merit Medical Systems stock. AQR Capital Management LLC raised its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) by 7.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,361 shares of the medical instruments supplier's stock after acquiring an additional 1,114 shares during the period. AQR Capital Management LLC's holdings in Merit Medical Systems were worth $1,730,000 as of its most recent filing with the Securities and Exchange Commission. 99.66% of the stock is owned by institutional investors.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.